X4 Pharmaceuticals (XFOR) EPS (Basic) (2017 - 2025)
X4 Pharmaceuticals (XFOR) posted EPS (Basic) of -$0.57 for Q4 2025, up 17.87% on a QoQ basis from -$0.69 in Q3 2025, and up 90.49% year-over-year from -$0.3 in Q4 2024.
X4 Pharmaceuticals (XFOR) EPS (Basic) (2017 - 2025) Analysis & Trends
X4 Pharmaceuticals' EPS (Basic) history runs 9 years deep, the most recent figure standing at -$0.57 for Q4 2025.
- Quarterly EPS (Basic) rose 90.49% year-over-year to -$0.57 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.87 (up 66.5% YoY) and the FY2025 annual result came in at -$1.87, up 66.54% from the prior year.
- EPS (Basic) was -$0.57 for Q4 2025 at X4 Pharmaceuticals, up from -$0.69 in the prior quarter.
- Across five years, EPS (Basic) topped out at $13.6 in Q2 2024 and bottomed at -$41.84 in Q4 2021.
- A 5-year average of -$10.78 and a median of -$6.86 in 2024 frame the typical range for EPS (Basic).
- Peak annual rise in EPS (Basic) reached 237.24% in 2024, while the deepest fall reached 1459.37% in 2024.
- X4 Pharmaceuticals' EPS (Basic) stood at -$41.84 in 2021, then jumped by 67.15% to -$13.75 in 2022, then surged by 76.52% to -$3.23 in 2023, then slumped by 84.13% to -$5.94 in 2024, then soared by 90.49% to -$0.57 in 2025.
- Business Quant data shows XFOR's EPS (Basic) at -$0.57 in Q4 2025, -$0.69 in Q3 2025, and -$3.47 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 0.00 |
| 4 | BeOne Medicines | 468.11 Bn | 463.32 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 122.48 Bn | 115.23 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.55 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | 0.00 |
| 8 | Argenx Se | 55.66 Bn | 50.47 Bn | 1.41 Bn | 7.59 |
| 9 | Alnylam Pharmaceuticals | 37.42 Bn | 34.41 Bn | 959.66 Mn | 1.55 |
| 10 | X4 Pharmaceuticals | 162.83 Mn | -54.22 Mn | 2.20 Mn | -0.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.57 |
| Sep 30, 2025 | -0.69 |
| Jun 30, 2025 | -3.47 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | -5.94 |
| Sep 30, 2024 | -5.47 |
| Jun 30, 2024 | 13.60 |
| Mar 31, 2024 | -7.77 |
| Dec 31, 2023 | -3.23 |
| Sep 30, 2023 | -0.35 |
| Jun 30, 2023 | -9.91 |
| Mar 31, 2023 | -4.94 |
| Dec 31, 2022 | -13.75 |
| Sep 30, 2022 | -7.89 |
| Jun 30, 2022 | -17.96 |
| Mar 31, 2022 | -21.54 |
| Dec 31, 2021 | -41.84 |
| Sep 30, 2021 | -22.75 |
| Jun 30, 2021 | -22.21 |
| Mar 31, 2021 | -38.92 |